Presentations from ISPOR 2019

OHE staff recently attended the ISPOR annual conference in New Orleans. In this blog post, we share a selection of our presentations. OHE staff recently attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 conference in New Orleans.…

OHE staff recently attended the ISPOR annual conference in New Orleans. In this blog post, we share a selection of our presentations.

OHE staff recently attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 conference in New Orleans. In this blog post, we share a selection of our presentations.

Lies, Damned Lies and Cost-Effectiveness: Open-Source Models from Office of Health Economics

THE CLINICAL AND ECONOMIC VALUE OF GENETIC SEQUENCING IN CANCER CARE from Office of Health Economics

MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION MAKING? from Office of Health Economics

Real option value drugs: is it really an option? from Office of Health Economics

News & Insights

Latest Research & Publications

Understanding the Full Value of Long-Acting Therapies: less is more?

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Analysing Global Immunisation Expenditure

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

The Importance of Diversity of Supply in Rare Diseases Markets

2023 OHE Annual Report to the Charity Commission

Employer Costs from Respiratory Infections

All Publications

Presentations from ISPOR 2019

Related News

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Funding Challenges in the Malaysian Health Care System

OHE at HESG Winter 2020

Share on Mastodon